Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Former healthcare CEO sentenced to 5 years in prison for role in $212M fraud conspiracy

Parmjit “Paul” Parmar, 55, from New Jersey has also been ordered to pay $125 million in restitution. The scheme to defraud investors was uncovered in 2017.  

emergency department

Analysis: The public may not be wrong to think of the ED as the ‘front door’ of the hospital

The perception is probably more pronounced in community hospital EDs than their academic counterparts. 

physician burnout

Physicians are quitting sooner, younger and for different priorities than in years past

Physicians who walk away from medicine before reaching their 25th year of practice tend to quit mainly due to the stress and hassles of the job.

UnitedHealth Group - 2

UnitedHealthcare looks to reduce prior authorizations by 30% before end of 2026

The insurance arm of UnitedHealth Group said the shift is part of its ongoing effort to eliminate the barriers between care delivery and medical coverage. The full list of services exempt from prior authorizations includes diagnostic tests and many outpatient surgeries.

North Carolina State Capitol Raleigh

Atrium Health looking to scoop up smaller nonprofit health system in $2B deal

WakeMed, a three-hospital system in the North Carolina capital region of Raleigh, would become part of Advocate Health, Atrium’s parent company, if the deal goes through. Advocate is one of the largest not-for-profit health systems in the U.S. 

Johnson & Johnson

Johnson & Johnson becomes the latest pharmaceutical company to sign on to TrumpRx

The New Jersey-based drug developer joins AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer in offering products directly to patients at a discounted rate. Johnson & Johnson is currently listing four medications on the platform.

overweight patient seeking health advice

FDA moves to restrict compounded versions of popular GLP-1 weight loss drugs

The agency said it is seeking to exclude semaglutide, tirzepatide and liraglutide from the 503B program based on a lack of clinical evidence. Unless there’s a shortage, the pharmaceuticals would be barred from being compounded by third-parties for the purpose of treating diabetes or obesity. The FDA is seeking public comment on the proposal. 

doctorwithpatient.jpg

Virtual nursing staff may help save cardiology departments from burnout

The idea is spreading thanks to a new startup focused on providing support for cardiologists.